Nuclear imaging of the stomach of healthy dogs.
To evaluate the use of technetium pertechnetate (99mTcO4) as a means of estimating gastric mucosal integrity, nuclear images of the empty stomach were obtained from 6 dogs at 20, 40, 60, 120, 180, and 240 minutes after IV administration of the radiopharmaceutical. Blood and gastric secretion samples were collected during the same time intervals. The left lateral-view image of the stomach was used to calculate the relative fraction of the dose in the stomach and the count density ratio. Between 20 and 40 minutes and 40 and 60 minutes, significant differences (P less than 0.001) were apparent in the amount of 99mTcO4 in the stomach. Blood concentration of 99mTcO4 decreased significantly (P less than 0.001), whereas gastric secretion concentration increased significantly (P less than 0.001) over time. Qualitative assessment of the gastric nuclear scans and the statistical analytic results indicated that the optimal time for imaging the canine stomach was between 40 and 60 minutes after radiopharmaceutical administration. In a second study, the same dogs were pretreated with the H2-receptor antagonist cimetidine and the cholinergic antagonist glycopyrrolate to block gastric secretions. Over time, changes in the relative dose fraction in the stomach and the density ratio were the same as values obtained during the experiment performed without use of cimetidine and glycopyrrolate. Results of the study indicate that nuclear imaging with 99mTcO4 outlines normal canine gastric mucosa and that pretreatment with cimetidine and glycopyrrolate has no effect on the quality of the gastric image.
Berardi
C
C
Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana 61801.
Twardock
A R
AR
Wheaton
L G
LG
Schaeffer
D J
DJ
D000818:Animals; D002927:Cimetidine / Q000494:pharmacology; D004285:Dogs / Q000033:anatomy & histology*; D005750:Gastric Juice / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D005753:Gastric Mucosa / Q000000981:diagnostic imaging* / Q000187:drug effects / Q000378:metabolism; D006024:Glycopyrrolate / Q000494:pharmacology; D015999:Multivariate Analysis; D011877:Radionuclide Imaging; D013670:Sodium Pertechnetate Tc 99m / Q000097:blood / Q000493:pharmacokinetics
D002927:Cimetidine; D013670:Sodium Pertechnetate Tc 99m; D006024:Glycopyrrolate